<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02787018</url>
  </required_header>
  <id_info>
    <org_study_id>IRC/641/015</org_study_id>
    <nct_id>NCT02787018</nct_id>
  </id_info>
  <brief_title>Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block</brief_title>
  <official_title>Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B.P. Koirala Institute of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B.P. Koirala Institute of Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to compare the effectiveness of dexamethasone and dexmedetomidine as
      an adjuvant to 0.5% ropivacaine for supraclavicular brachial plexus block on the onset of
      block and duration of analgesia, so that the investigators can choose the better adjuvant for
      the investigators routine practice of regional anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ropivacaine is a newer local anesthetic which is structurally related to bupivacaine, but has
      fewer side effects. It is more cardio stable than bupivacaine, but the onset of action is
      delayed and the duration of action is shorter than bupivacaine making its use during regional
      anesthesia less preferable to many anesthesiologists. Steroids like dexamethasone, or alpha-2
      agonists like dexmedetomidine are being studied as adjuvants to ropivacaine for brachial
      plexus block to improve its anesthetic properties and have shown favorable outcome in terms
      of shortening the onset of block and prolonging the duration of action. But no study has been
      done to compare their effects. So in this study the investigators want to compare the
      effectiveness of dexamethasone and dexmedetomidine as an adjuvant to 0.5% ropivacaine for
      supraclavicular brachial plexus block on the onset of block and duration of analgesia, so
      that the investigators can choose the better adjuvant for the investigators routine practice
      of regional anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Onset of sensory block</measure>
    <time_frame>every 3 minutes until 45 minutes after injection of drug</time_frame>
    <description>Sensory block in the territories of median nerve (palmar surface of index finger), ulnar nerve (palmar surface of little finger), radial nerve (dorsal surface of first web space/ thumb) and musculocutaneous nerve (lateral side of volar surface of forearm) will be assessed by pinprick test using a 3‑point scale:
0 ‑ normal sensation,
‑ loss of sensation of pinprick (analgesia),
‑ loss of sensation of touch (anaesthesia). Complete sensory block will be defined as grade 2 sensory block in 3 or more nerve territories.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Onset of motor block</measure>
    <time_frame>every 3 minutes until 45 minutes after injection of drug</time_frame>
    <description>Motor block will be evaluated by thumb flexion/ opposition (median nerve), thumb extension (radial nerve), finger abduction (ulnar nerve) and elbow flexion with forearm in full supination (musculocutaneous nerve) on a 3‑point scale for motor function:
0 ‑ normal motor function,
‑ reduced motor strength but able to move,
‑ complete motor block. Complete motor block will be defined as grade 2 motor block in 3 or more nerve territories.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of analgesia</measure>
    <time_frame>Up to 24 hours after onset of block</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of sensory block</measure>
    <time_frame>Up to 24 hours after onset of block</time_frame>
    <description>time from onset of sensory block to complete recovery of anaesthesia on all nerves.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of motor block</measure>
    <time_frame>Up to 24 hours after onset of block</time_frame>
    <description>time from onset of motor block to the recovery of complete motor function of the hand and forearm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of side effects of drugs</measure>
    <time_frame>Forty-eight hours following the injection of local anesthetics</time_frame>
    <description>Side effects like bradycardia, tachycardia, hypotension, sedation, neurological deficit will be evaluated</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Brachial Plexus Block</condition>
  <arm_group>
    <arm_group_label>Block with Ropivacaine and Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive brachial plexus block with 20 ml 0.5% ropivacaine with 1ml normal saline: Total volume 21 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Block with Ropivacaine and Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive brachial plexus block with 20ml 0.5% ropivacaine with 4mg (1ml) dexamethasone: Total volume 21 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Block with Ropivacaine and Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive brachial plexus block with 20ml 0.5% ropivacaine with 50mcg (1ml) dexmedetomidine: Total volume 21 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and Normal saline</intervention_name>
    <description>Supraclavicular brachial plexus block will be given with 0.5% ropivacaine with 1 ml normal saline</description>
    <arm_group_label>Block with Ropivacaine and Normal saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and Dexamethasone</intervention_name>
    <description>Supraclavicular brachial plexus block will be given with 0.5% ropivacaine with 4mg (1ml) dexamethasone</description>
    <arm_group_label>Block with Ropivacaine and Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and Dexmedetomidine</intervention_name>
    <description>Supraclavicular brachial plexus block will be given with 0.5% ropivacaine with 50 mcg (1ml) dexmedetomidine</description>
    <arm_group_label>Block with Ropivacaine and Dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of American Society of Anesthesiologists Physical Status I and II undergoing
             elective upper limb surgery under supraclavicular brachial plexus block

        Exclusion Criteria:

          -  Patient's refusal to participate

          -  Patients weighing less than 40 kg

          -  Allergy to study drugs

          -  Infection at the site of injection

          -  Patients with preexisting neurological deficit

          -  Patients with diabetes mellitus

          -  Patients on steroids preoperatively

          -  Patients with bleeding disorder or coagulopathy

          -  Abnormalities in ECG like AV block or symptomatic bradycardia

          -  Patients receiving adrenoreceptor agonist or antagonist therapy preoperatively

          -  Requirement of conversion to general anesthesia due to inadequate block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Parineeta Thapa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>BPKIHS, Dharan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Murari L Das, MD</last_name>
    <phone>+977-25-525555</phone>
    <phone_ext>5279</phone_ext>
    <email>irc@bpkihs.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Balkrishna Bhattarai, MD</last_name>
    <phone>+977-25-525555</phone>
    <phone_ext>2006</phone_ext>
    <email>bhattaraibk@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>B. P. Koirala Institute of Health Sciences</name>
      <address>
        <city>Dharan</city>
        <state>Sunsari</state>
        <country>Nepal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Murari L Das, MD</last_name>
      <phone>+977-25-525555</phone>
      <phone_ext>5279</phone_ext>
      <email>irc@bpkihs.edu</email>
    </contact>
    <contact_backup>
      <last_name>Balkrishna Bhattarai, MD</last_name>
      <phone>+977-25-525555</phone>
      <phone_ext>2006</phone_ext>
      <email>bhattaraibk@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Parineeta Thapa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asish Subedi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <reference>
    <citation>Choi S, Rodseth R, McCartney CJ. Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2014 Mar;112(3):427-39. doi: 10.1093/bja/aet417. Epub 2014 Jan 10. Review.</citation>
    <PMID>24413428</PMID>
  </reference>
  <reference>
    <citation>Das A, Majumdar S, Halder S, Chattopadhyay S, Pal S, Kundu R, Mandal SK, Chattopadhyay S. Effect of dexmedetomidine as adjuvant in ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded and randomized controlled study. Saudi J Anaesth. 2014 Nov;8(Suppl 1):S72-7. doi: 10.4103/1658-354X.144082.</citation>
    <PMID>25538527</PMID>
  </reference>
  <reference>
    <citation>Kumar S, Palaria U, Sinha AK, Punera DC, Pandey V. Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesth Essays Res. 2014 May-Aug;8(2):202-8. doi: 10.4103/0259-1162.134506.</citation>
    <PMID>25886227</PMID>
  </reference>
  <reference>
    <citation>Zhang Y, Wang CS, Shi JH, Sun B, Liu SJ, Li P, Li EY. Perineural administration of dexmedetomidine in combination with ropivacaine prolongs axillary brachial plexus block. Int J Clin Exp Med. 2014 Mar 15;7(3):680-5. eCollection 2014.</citation>
    <PMID>24753763</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2016</study_first_submitted>
  <study_first_submitted_qc>May 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2016</study_first_posted>
  <last_update_submitted>August 20, 2017</last_update_submitted>
  <last_update_submitted_qc>August 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>B.P. Koirala Institute of Health Sciences</investigator_affiliation>
    <investigator_full_name>Parineeta Thapa</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Brachial plexus block</keyword>
  <keyword>Ropivacaine</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Dexamethasone</keyword>
  <keyword>Adjuvants, anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

